Clinical Trials for Prinicipal Investigator: Samuel Ejadi

1 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
NRG-HN001 Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA) Open